Dianthus Therapeutics
Clinical trials sponsored by Dianthus Therapeutics, explained in plain language.
-
New drug could extend relief for rare nerve disorder
Disease control Recruiting nowThis study tests a new drug called DNTH103 in 36 adults with multifocal motor neuropathy, a rare condition that causes muscle weakness. The goal is to see if the drug is safe and can delay the need for standard immunoglobulin therapy. Participants will receive either the drug or …
Phase: PHASE2 • Sponsor: Dianthus Therapeutics • Aim: Disease control
Last updated May 17, 2026 08:05 UTC
-
New drug aims to control rare nerve disorder in major trial
Disease control Recruiting nowThis study tests a new medicine called DNTH103 (claseprubart) for adults with chronic inflammatory demyelinating polyneuropathy (CIDP), a condition where the immune system attacks nerves, causing weakness and disability. The trial will compare the drug to a placebo in 256 people …
Phase: PHASE3 • Sponsor: Dianthus Therapeutics • Aim: Disease control
Last updated May 17, 2026 08:03 UTC